These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17915369)

  • 1. [Observational study of an AT1-antagonist].
    Klocke RK; Landen H
    MMW Fortschr Med; 2007 Aug; 149(33-34):37. PubMed ID: 17915369
    [No Abstract]   [Full Text] [Related]  

  • 2. A review of the benefits of early treatment initiation with single-pill combinations of telmisartan with amlodipine or hydrochlorothiazide.
    Segura J; Ruilope LM
    Vasc Health Risk Manag; 2013; 9():521-8. PubMed ID: 24082785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Importance of a fixed combination of AT1-receptor blockade and hydrochlorothiazide for blood pressure lowering in cardiac risk patients. A postmarketing surveillance study with candesartan/HCTZ].
    Bramlage P; Schönrock E; Odoj P; Wolf WP; Funken C
    MMW Fortschr Med; 2008 Feb; 150(6):40. PubMed ID: 18323344
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term, open-label evaluation of the safety and efficacy of telmisartan 80 mg/hydrochlorothiazide 25 mg fixed-dose combination alone or with other antihypertensive medication.
    Neldam S; Edwards C
    Expert Opin Pharmacother; 2009 Feb; 10(3):345-52. PubMed ID: 19191674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study.
    Ma L; Wang W; Zhao Y; Zhang Y; Deng Q; Liu M; Sun H; Wang J; Liu L
    Am J Cardiovasc Drugs; 2012 Apr; 12(2):137-42. PubMed ID: 22329591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Telmisartan (micardis) -- an antagonist of angiotensin 2 of type 1 receptors: another antihypertensive drug or something greater?].
    Chazova IE
    Ter Arkh; 2003; 75(6):89-91. PubMed ID: 12920969
    [No Abstract]   [Full Text] [Related]  

  • 7. Improving hypertension control in patients at cardiovascular risk: the case for telmisartan-based therapy.
    Aalbers J
    Cardiovasc J Afr; 2011; 22(1):45-6. PubMed ID: 21298207
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review and meta-analysis of telmisartan versus valsartan in the management of essential hypertension.
    Zheng Z; Lin S; Shi H
    J Clin Hypertens (Greenwich); 2010 Jun; 12(6):414-21. PubMed ID: 20591086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A fixed dose combination of telmisartan, and a thiazide diuretic in the treatment of hypertension].
    Vítovec J; Slíva J
    Vnitr Lek; 2013 May; 59(5):397-401. PubMed ID: 23767455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension--a randomised ABPM study.
    Neutel JM; Kolloch RE; Plouin PF; Meinicke TW; Schumacher H;
    J Hum Hypertens; 2003 Aug; 17(8):569-75. PubMed ID: 12874615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on telmisartan/hydrochlorothiazide combinations for the management of hypertensive patients with additional cardiovascular risk factors.
    Kjeldsen S; Mancia G; Schmieder R; Mattheus M; Unger T
    Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):673-82. PubMed ID: 23750676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, statistical analysis and sample size calculation of dose response study of telmisartan and hydrochlorothiazide.
    Horie Y; Higaki J; Takeuchi M
    Contemp Clin Trials; 2007 Sep; 28(5):647-53. PubMed ID: 17389151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of fixed dose combination (FDC) of telmisartan+ramipril usage in patients with micro-albuminuria and persistent hypertension: A TRIUMPH study.
    Sharma A; Baliga V;
    J Indian Med Assoc; 2008 Mar; 106(3):191-4, 196. PubMed ID: 18712142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of telmisartan, a selective AT1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension. TEES Study Group.
    Karlberg BE; Lins LE; Hermansson K
    J Hypertens; 1999 Feb; 17(2):293-302. PubMed ID: 10067800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The angiotensin II receptor antagonist telmisartan reduces urinary albumin excretion in patients with isolated systolic hypertension: results of a randomized, double-blind, placebo-controlled trial.
    Vogt L; Navis G; Köster J; Manolis AJ; Reid JL; de Zeeuw D;
    J Hypertens; 2005 Nov; 23(11):2055-61. PubMed ID: 16208149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of efficacy, safety and tolerability of fixed dose combination of telmisartan 40mg and hydrochlorothiazide 12.5mg in adult Indian patients with mild to moderate hypertension.
    Jayaram S; Lahoti S; Chandrasekharan S; Ganesan R; Muralidharan RS; Mishra AB; Sodhi SS; Rajadhyaksha GC; Jain SD; Kadam GS; Gawde A; Desai A
    J Indian Med Assoc; 2004 Sep; 102(9):525-7. PubMed ID: 15887845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telmisartan: a review of its use in the management of hypertension.
    Battershill AJ; Scott LJ
    Drugs; 2006; 66(1):51-83. PubMed ID: 16398568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ONTARGET, TRANSCEND and PROFESS--clarifying, confusing or misleading?
    Oparil S; Kjeldsen SE; Hedner T; Narkiewicz K
    Blood Press; 2009; 18(1-2):4-6. PubMed ID: 19191085
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolic approaches to antihypertensive treatment in diabetic patients.
    Cicero AF; Tocci G
    Hypertens Res; 2015 Dec; 38(12):802-3. PubMed ID: 26423788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.